Dobutamine 12.5mg/ml Concentrate for solution for infusion Malta - inglês - Medicines Authority

dobutamine 12.5mg/ml concentrate for solution for infusion

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

Hospira Dobutamine 12.5 mg/mL Sterile Concentrate 250 mg/20 mL vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

hospira dobutamine 12.5 mg/ml sterile concentrate 250 mg/20 ml vial

hospira australia pty ltd - dobutamine hydrochloride, quantity: 14.01 mg/ml (equivalent: dobutamine, qty 12.5 mg/ml) - injection, concentrated - excipient ingredients: sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - dobutamine is indicated for adults who require inotropic support in the treatment of low output cardiac failure associated with organic heart disease, myocardial infarction, open heart surgery, cardiomyophathies, septic shock and cardiogenic shock. dobutamine can increase or maintain cardiac output during positive end expiratory pressure ventilation.

Dobutamine Hydrochloride Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

dobutamine hydrochloride

hospira nz ltd - dobutamine hydrochloride 14.01 mg/ml equivalent to 12.5 mg/ml dobutamine - solution for injection - 12.5 mg/ml - active: dobutamine hydrochloride 14.01 mg/ml equivalent to 12.5 mg/ml dobutamine excipient: sodium metabisulfite water for injection

Dobutamine in 5% Dextrose Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

dobutamine in 5% dextrose

hospira nz ltd - dobutamine hydrochloride 0.56 mg/ml equivalent to 0.5 mg/ml dobutamine - solution for infusion - 0.5 mg/ml - active: dobutamine hydrochloride 0.56 mg/ml equivalent to 0.5 mg/ml dobutamine excipient: disodium edetate dihydrate glucose monohydrate sodium metabisulfite water for injection

Dobutamine in 5% Dextrose Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

dobutamine in 5% dextrose

hospira nz ltd - dobutamine hydrochloride 1.12 mg/ml equivalent to 1 mg/ml dobutamine - solution for infusion - 1 mg/ml - active: dobutamine hydrochloride 1.12 mg/ml equivalent to 1 mg/ml dobutamine excipient: disodium edetate dihydrate glucose monohydrate sodium metabisulfite water for injection

Dobutamine in 5% Dextrose Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

dobutamine in 5% dextrose

hospira nz ltd - dobutamine hydrochloride 2.24 mg/ml equivalent to 2.0 mg/ml dobutamine - solution for infusion - 2 mg/ml - active: dobutamine hydrochloride 2.24 mg/ml equivalent to 2.0 mg/ml dobutamine excipient: disodium edetate dihydrate glucose monohydrate sodium metabisulfite water for injection

DOBUTAMINE PFIZER Irlanda - inglês - HPRA (Health Products Regulatory Authority)

dobutamine pfizer

pfizer healthcare ireland - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml

DOBUTAMINE-HAMELN 250 MG/20 ML AMPOULE Irlanda - inglês - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/20 ml ampoule

hameln pharmaceuticals gmbh - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml

DOBUTAMINE-HAMELN 250 MG/ 5 ML AMPOULE Irlanda - inglês - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/ 5 ml ampoule

hameln pharmaceuticals gmbh - dobutamine hydrochloride - concentrate for soln for inf - 50 mg/ml

DOBUTAMINE-HAMELN 250 MG/ 50 ML VIAL Irlanda - inglês - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/ 50 ml vial

hameln pharmaceuticals gmbh - dobutamine hydrochloride - solution for infusion - 5 mg/ml